ArticleCancers2022
Thyroid Disease Prediction Using Selective Features and Machine Learning Techniques.
Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 127 citations in OpenAlex.
- Machine learning-based model for identifying liver injury in patients with thyroid-associated ophthalmopathy.International ophthalmology · 2026Article
- Machine learning improves detection of alpha thalassemia carriers compared to clinical features.Scientific reports · 2025Article
- Thyroid disease classification using generative adversarial networks and Kolmogorov-Arnold network for three-class classification.BMC medical informatics and decision making · 2025Article
- Leveraging machine learning in precision medicine to unveil organochlorine pesticides as predictive biomarkers for thyroid dysfunction.Scientific reports · 2025Article
- Divulging Patterns: An Analytical Review for Machine Learning Methodologies for Breast Cancer Detection.Journal of Cancer · 2025Review
- Review
- Analysis and interpretability of machine learning models to classify thyroid disease.PloS one · 2024Article
- Article
- Application of machine learning for mass spectrometry-based multi-omics in thyroid diseases.Frontiers in molecular biosciences · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 6 institutions in 5 countries.
Funding
Abstract
Thyroid disease prediction has emerged as an important task recently. Despite existing approaches for its diagnosis, often the target is binary classification, the used datasets are small-sized and results are not validated either. Predominantly, existing approaches focus on model optimization and the feature engineering part is less investigated. To overcome these limitations, this study presents an approach that investigates feature engineering for machine learning and deep learning models. Forward feature selection, backward feature elimination, bidirectional feature elimination, and machine learning-based feature selection using extra tree classifiers are adopted. The proposed approach can predict Hashimoto's thyroiditis (primary hypothyroid), binding protein (increased binding protein), autoimmune thyroiditis (compensated hypothyroid), and non-thyroidal syndrome (NTIS) (concurrent non-thyroidal illness). Extensive experiments show that the extra tree classifier-based selected feature yields the best results with 0.99 accuracy and an F1 score when used with the random forest classifier. Results suggest that the machine learning models are a better choice for thyroid disease detection regarding the provided accuracy and the computational complexity. K-fold cross-validation and performance comparison with existing studies corroborate the superior performance of the proposed approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.